GTC Biotherapeutics (fka GTCB)

[St_armands_man]

I agree that I think it will pass...

I also think it's already built into the price. While rarely would I support a RS, I think this may be a unique event. In the majority of cases, a RS is done by companies that have very little going for them. As for GTCB, I think we're now positioned for additional partnerships (the Ovation partnership strenghtens credability in the market) and positive news flow over the next year.

Having a stock at less than $1/share prevents most institutional investors from participating. The RS will allow them to get back into the stock and today's deal, combined with future news flow, will drive some higher institutional buying going forward.